Epygenix Therapeutics Announces FDA Acceptance of IND to Initiate a Clinical Trial of EPX-100 to Treat Lennox-Gastaut Syndrome Read more
UCB Announces BRIVIACT (brivaracetam) CV Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older Read more
Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancer Read more
Novartis sabatolimab receives orphan drug designation from the European Commission for myelodysplastic syndromes Read more
Novartis Leqvio (inclisiran) analyses show effective and sustained LDL-C reduction in two sub-populations of patients with ASCVD Read more
European Commission Approves BioMarin’s VOXZOGO (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close Read more
Forxiga approved in Japan for the treatment of chronic kidney disease in patients with and without type-2 diabetes Read more
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 Read more